Abstract

Purpose: RPGRIP1 encodes a ciliary protein expressed in the photoreceptor connecting cilium. Mutations in this gene cause ∼5% of Leber congenital amaurosis (LCA) worldwide, but are also associated with cone–rod dystrophy (CRD) and retinitis pigmentosa (RP) phenotypes. Our purpose was to clinically characterize RPGRIP1 patients from our cohort, collect clinical data of additional RPGRIP1 patients reported previously in the literature, identify common clinical features, and seek genotype–phenotype correlations.Methods: Clinical data were collected from 16 patients of our cohort and 212 previously reported RPGRIP1 patients and included (when available) family history, best corrected visual acuity (BCVA), refraction, comprehensive ocular examination, optical coherence tomography (OCT) imaging, visual fields (VF), and full-field electroretinography (ffERG).Results: Out of 228 patients, the majority (197, 86%) were diagnosed with LCA, 18 (7%) with RP, and 13 (5%) with CRD. Age of onset was during early childhood (n = 133, average of 1.7 years). All patients but 6 had moderate hyperopia (n = 59, mean of 4.8D), and average BCVA was 0.06 Snellen (n = 124; only 10 patients had visual acuity [VA] > 0.10 Snellen). On funduscopy, narrowing of blood vessels was noted early in life. Most patients had mild bone spicule-like pigmentation starting in the midperiphery and later encroaching upon the posterior pole. OCT showed thinning of the outer nuclear layer (ONL), while cystoid changes and edema were relatively rare. VF were usually very constricted from early on. ffERG responses were non-detectable in the vast majority of cases. Most of the mutations are predicted to be null (363 alleles), and 93 alleles harbored missense mutations. Missense mutations were identified only in two regions: the RPGR-interacting domain and the C2 domains. Biallelic null mutations are mostly associated with a severe form of the disease, whereas biallelic missense mutations usually cause a milder disease (mostly CRD).Conclusion: Our results indicate that RPGRIP1 biallelic mutations usually cause severe retinal degeneration at an early age with a cone–rod pattern. However, most of the patients exhibit preservation of some (usually low) BCVA for a long period and can potentially benefit from gene therapy. Missense changes appear only in the conserved domains and are associated with a milder phenotype.

Highlights

  • Leber congenital amaurosis (LCA) is considered as the most severe form of non-syndromic inherited retinal degeneration

  • The RPGRIP1 protein contains several domains: a coiled-coil domain, homologous to proteins involved in vesicular trafficking located at the N-terminus; two C2 domains, which are usually involved in targeting proteins to the cell membrane; a bipartite nuclear localization domain; a C-terminal RPGR-interacting domain; and two parts of seryl tRNA synthetase at the C- and Ntermini (Roepman et al, 2000; Koenekoop, 2005)

  • We recruited for the study Israeli and Palestinian individuals with various inherited retinal dystrophies (IRDs), including LCA, retinitis pigmentosa (RP), and cone–rod dystrophy (CRD)

Read more

Summary

Introduction

Leber congenital amaurosis (LCA) is considered as the most severe form of non-syndromic inherited retinal degeneration It is usually diagnosed during the first months of life and leads to severe visual impairment or total blindness already at an early age. It is characterized by oculo-digital signs, congenital nystagmus, hypermetropia, and non-recordable electroretinography (ERG) responses (Cremers et al, 2002; den Hollander et al, 2008; Kumaran et al, 2017). The longest isoform consists of 24 exons and is predicted to encode a protein product of 1,287 amino acids (Gerber et al, 2001; Koenekoop, 2005). The RPGRIP1 protein includes many phosphorylation, glycosylation, amidation, and myristoylation sites, as well as zinc fingers and leucine zipper structures

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call